KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Share-based Compensation (2016 - 2026)

Globus Medical filings provide 15 years of Share-based Compensation readings, the most recent being $11.4 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 4.11% to $11.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.8 million, a 8.14% decrease, with the full-year FY2025 number at $49.8 million, down 8.14% from a year prior.
  • Share-based Compensation hit $11.4 million in Q4 2025 for Globus Medical, down from $11.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $22.8 million in Q3 2023 to a low of $7.5 million in Q3 2021.
  • Median Share-based Compensation over the past 5 years was $10.2 million (2023), compared with a mean of $11.0 million.
  • Biggest five-year swings in Share-based Compensation: soared 173.69% in 2023 and later tumbled 46.34% in 2024.
  • Globus Medical's Share-based Compensation stood at $7.8 million in 2021, then increased by 8.99% to $8.5 million in 2022, then skyrocketed by 46.29% to $12.4 million in 2023, then dropped by 4.32% to $11.9 million in 2024, then dropped by 4.11% to $11.4 million in 2025.
  • The last three reported values for Share-based Compensation were $11.4 million (Q4 2025), $11.5 million (Q3 2025), and $13.6 million (Q2 2025) per Business Quant data.